Canine and Feline Parasite Control at Home and Abroad

Total Page:16

File Type:pdf, Size:1020Kb

Canine and Feline Parasite Control at Home and Abroad Vet Times The website for the veterinary profession https://www.vettimes.co.uk Canine and feline parasite control at home and abroad Author : Ian Wright Categories : Companion animal, Vets Date : June 13, 2016 ABSTRACT The European Scientific Counsel Companion Animal Parasites (ESCCAP) UK and Ireland is a national association of ESCCAP Europe, bringing together some of the UK and Ireland’s leading experts in the field of veterinary parasitology. ESCCAP UK and Ireland works with pet owners and professionals to raise awareness of the threat from parasites and provide relevant information and advice. Part of this service is to answer questions from the public and veterinary professionals asked via www.esccapuk.org.uk This article addresses the most common questions asked that are of particular relevance to veterinary professionals. The European Scientific Counsel Companion Animal Parasites (ESCCAP) UK and Ireland is a national association of ESCCAP Europe, bringing together some of the UK and Ireland’s leading experts in the field of veterinary parasitology. 1 / 11 Figure 1. Flea bite reaction. ESCCAP UK and Ireland is independent, working with pet owners and professionals to raise awareness of the threat from parasites and provide relevant information and advice. Part of this service is to answer questions from the public and veterinary professionals, asked via www.esccapuk.org.uk Some questions are specific to individual circumstances, such as trematodes present in Asia and parasites present in the Middle East. Others, however, are asked frequently and of more general relevance to UK veterinary professionals. Some examples are discussed in this article and fall into four broad categories: ectoparasite control in households macrocyclic lactone use European pet travel advice Babesia canis prevention in dogs Ectoparasite control in households Questions are often asked about parasites found in the home – either when life stages are discovered in the house or when ectoparasites are found on pets. How do I deal with fleas biting me in my home? 2 / 11 People are most commonly bitten by cat fleas emerging from pupae and feeding for the first time. Although they cannot survive on people, they can inflict bites with significant skin reactions (Figure 1). These bites can occur from flea infestations being maintained by the owner’s pets, stray cats or wildlife entering the home, or when people enter homes that have been vacated for long periods with pupae lying dormant. If people in the household do not own pets and bar entry to other animals entering the home then environmental treatment alone will rapidly reduce the number of bites. This may also be required if the home is invaded by avian fleas from abandoned nests in attic spaces or chimneys. Pyrethroid sprays containing growth inhibitors are effective, but if the source of the infestation is not clear, whole house fumigation may be required. If pets are present in the home to allow flea reproduction then a multiple-pronged strategy is required. Adulticide Using an effective adulticide can prevent egg laying and break the reproductive cycle. Adulticides must kill 100% of fleas before they can lay eggs. Adult fleas can lay eggs within 24 hours, so an effective flea treatment must kill fleas at least within that time. They must also be administered frequently enough to continue to prevent egg laying. The time after application at which fleas survive long enough in the presence of the product to lay eggs is known as the “reproductive break point”. If the reproductive break point is reached then flea control will fail. Effective environmental control 3 / 11 Figure 2. Book lice. Directly reducing the numbers of eggs, larvae and pupae in the environment will decrease the time required to bring an infestation under control. This may be achieved using environmental sprays containing a pyrethroid, such as permethrin or deltamethrin (both for dogs), and a growth inhibitor. Lufenuron can also be used in pets systemically to prevent flea eggs from hatching. Some adulticide flea treatments, such as imidacloprid and selamectin, will subsequently be shed into the environment, reducing environmental egg and larval contamination. Many spot-on flea products also contain growth regulator S-methoprene to achieve a similar effect. Daily vacuuming of areas frequented by infested pets has also been demonstrated to reduce pupae in the environment. Flea infestations take at least three months to eliminate – often much longer – with nine-month treatment regimens often required (Dryden et al, 2000). This needs to be made clear to clients so they are prepared for long periods of treatment before fleas are eliminated – and so they do not rapidly become disheartened. It is also important to establish whether fleas are present at all. Insect life stages have been presented to the author, which owners believed to be parasitic life stages attacking them in the home. Examples are book lice (Figure 2), which look like bed bugs, but are, in fact, free-living insects. They congregate around food bowls, making pet owners sometimes think they are fleas or lice. Plant seeds (Figure 3) may sometimes be mistaken for flea eggs and flea larvae (Figure 4) are sometimes presented in the belief they are attacking owners. Although this life stage feeds on detritus and flea dirt, it is a sign flea infestation is present in the home. 4 / 11 Adult cat fleas may be identified by their laterally flattened appearance and head combs (Figure 5). Can ticks infest my home like fleas? Ixodes species ticks are predominant in the UK and have a life cycle of three years. In temperate climates, each life cycle feeding stage does so only once per year, so takes three years from egg to adult. The larval stage that feeds in the first year requires small hosts, such as rodents and songbirds. As a result of these factors, it is unlikely Ixodes ticks will establish in UK homes and exposure takes place primarily outdoors. Figure 3. Plant seed casing. Dermacentor and Rhipicephalus species have similar life cycles, with the potential to complete them more quickly; in the case of Rhipicephalus, often within one season. This allows it to potentially take advantage of increased temperatures in central-heated homes and become established in households in a similar way to fleas. It has not yet formed endemic foci in the UK, but two cases of house infestation have been recorded in south England (Hansford et al, 2015). These cases were from dogs imported from Europe and at least one had been tick-treated before admission. 5 / 11 Nymphs of Rhipicephalus survived and, once established, took more than 12 months to eliminate, despite effective tick treatment of pets and repeated fumigation of the house. This demonstrates both the importance of checking dogs that have been tick-treated for ticks and also rapid reporting and identification of ticks found in the home. Macrocyclic lactone use Can you use milbemycin oxime or moxidectin in collies/related breeds? Concern exists among veterinary professionals and the public regarding the use of macrocyclic lactones (avermectins and milbemycins) in collies and related breeds. This is due to these breeds carrying the multi-drug resistance one (MDR1) gene, making them susceptible to ivermectin crossing the blood-brain barrier. However, licensed macrocyclic lactones – including moxidectin, milbemycin and selamectin – have all been demonstrated to be safe in collies (see individual data sheets). The safety margin of overdose is narrower in these breeds, however, so it is important to dose accurately and make owners aware of the risk of overdose. They should also be avoided in these breeds where therapeutic indication is to use them at increased frequency, such as weekly use of moxidectin for treatment of Demodex. Can moxidectin and milbemycin be used together? The popularity, high efficacy and good compliance with many clients achieved with tablets containing milbemycin oxime and spot-on preparations containing moxidectin, has led to a desire to use them together. However, the two drugs are not licensed to use together in any formulation and, so far, safety data is limited to small case studies. Even if larger studies demonstrating safety were published, without a license it is hard to justify their combined use, given the similar spectrums of activity. Both being milbemycins, they are very closely related, making the possibility of combined overdose more likely. This is of particular concern in collies and other dogs carrying the MDR1 gene, where macrocyclic lactones already have a narrower margin of safety. One argument for combined usage is the addition of praziquantel in many milbemycin tablet products. A wide variety of tablets containing praziquantel without milbemycin are available, if moxidectin spot-on preparations are preferred and tapeworm treatment is required. No grounds exist, therefore, on which combined use can be justified and if there was an adverse 6 / 11 reaction to their combined use then defending this course of action would be difficult. On evidence, ESCCAP UK and Ireland can, in no way, support their combined use. European pet travel advice ESCCAP UK and Ireland receives frequent questions surrounding pet travel. The most common are regarding tapeworm and tick travel requirements under the Pet Travel Scheme (PETS) and confusion around travel to the Republic of Ireland. Are tapeworm and tick treatments still a PETS requirement? Tick treatments have ceased to be compulsory for dogs travelling to the UK. This is perceived to have been a factor in the establishment of Rhipicephalus sanguineus in households in south England and in the introduction of babesiosis to the UK. Although it is likely maintaining the compulsory treatment would have slowed down the introduction of foreign ticks and tick-borne diseases affecting canids, this is not why it was established. Like all compulsory PETS treatments, it was put in place to stop human tick-borne disease entering the country – primarily Mediterranean spotted fever caused by Rickettsia conorii.
Recommended publications
  • Veterinary Guide to Resistance & Parasites
    Veterinary Guide to Resistance & Parasites How to make the Get Rotation Right deworming strategy part of your equine health wellness protocol. ||||||||||||||||||||||||||||||||||||||||| GET ROTATION RIGHT Resistant parasites – veterinary involvement is needed now. Deworming has come a long way in the past 50 years – from products that were nearly toxic and required complicated tubing to the easy-to-administer dewormers we know now. As more horse owners recognize the value of regular deworming, past troublemakers such as large strongyles have become much less of a threat. Still, deworming is nothing to take lightly. As internal parasites become more resistant, your expertise is needed Horseowners unknowingly more than ever to make sure deworming programs remain efficient contribute to resistance. and effective. Only with veterinary involvement will we control parasite • Rotating brand names, not populations, combat resistance and get rotation right. chemical classes – general confusion about when and RESISTANCE IS REAL: MULTIPLE DRUGS, MULTIPLE PARASITES. how to use different classes • No new drug class since avermectins in 1981. of dewormers. • Benzimidazole resistance in cyathostomes.1-3 • Lack of knowledge about • Pyrantel resistance in cyathostomes and ascarids.4-8,11 resistance issues. • Ivermectin and moxidectin resistance among ascarids.8,9,11 • Deworming many horses more • Early warning signs of macrocyclic-lactone-resistant cyathostomes.10 frequently than necessary. • Health-related issues caused by parasites: • Misunderstanding about the ~ Ascarids (roundworms) unique properties of larvicidal Verminous pneumonia: cough, nasal discharge, low-grade fever treatments and how to maximize Unthriftiness – rough hair coat their efficacy. Intestinal obstruction/colic • Underdosing their horses. Intestinal perforation leading to peracute death Decreased performance and reduced weight gain ~ Cyathostomes (small strongyles) Most common in young and old horses, but can afflict any horse.
    [Show full text]
  • WSAVA List of Essential Medicines for Cats and Dogs
    The World Small Animal Veterinary Association (WSAVA) List of Essential Medicines for Cats and Dogs Version 1; January 20th, 2020 Members of the WSAVA Therapeutic Guidelines Group (TGG) Steagall PV, Pelligand L, Page SW, Bourgeois M, Weese S, Manigot G, Dublin D, Ferreira JP, Guardabassi L © 2020 WSAVA All Rights Reserved Contents Background ................................................................................................................................... 2 Definition ...................................................................................................................................... 2 Using the List of Essential Medicines ............................................................................................ 2 Criteria for selection of essential medicines ................................................................................. 3 Anaesthetic, analgesic, sedative and emergency drugs ............................................................... 4 Antimicrobial drugs ....................................................................................................................... 7 Antibacterial and antiprotozoal drugs ....................................................................................... 7 Systemic administration ........................................................................................................ 7 Topical administration ........................................................................................................... 9 Antifungal drugs .....................................................................................................................
    [Show full text]
  • These Ain't Your Father's Parasites: Dewormer Resistance and New Strategies for Parasite Control in Horses
    These Ain't Your Father's Parasites: Dewormer Resistance and New Strategies for Parasite Control in Horses Ray M. Kaplan, DVM, PhD, DEVPC Department of Infectious Diseases College of Veterinary Medicine University of Georgia Athens, Georgia 30602 Summary Most veterinarians continue to recommend anthelmintic (dewormer) treatment programs for horses that are based on knowledge and concepts that are more than 40 years old. However, recent studies demonstrate that resistance and multiple-drug resistance in equine parasites is extremely common, but few horse owners or veterinarians take this into account when making treatment decisions. Parasites are highly over-dispersed in hosts, such that a small percentage of hosts (20%) harbor most (80%) of the parasites. The common practices of recommending the same treatment program for all horses despite great differences in parasite burdens, of recommending frequent preventive treatment of all horses without any indication of parasitic disease or knowing what species of parasites are present, of recommending the use of drugs without knowledge of their efficacy, of failing to perform fecal egg count surveillance and of failing to determine if treatments are effective, are all incompatible with achieving optimal and sustainable parasite control. Consequently, it is necessary that attitudes and approaches for parasite control in horses undergo a complete overhaul, and that both horse owners and veterinarians become educated in these important issues. Introduction The introduction of benzimidazole (BZ) anthelmintics (dewormers) led to a revolution in equine in parasite control (Drudge and Lyons 1966). With these new tools came new recommendations; horse owners were advised to deworm all horses every 8 weeks.
    [Show full text]
  • The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
    WHO/PSM/QSM/2006.3 The use of stems in the selection of International Nonproprietary Names (INN) for pharmaceutical substances 2006 Programme on International Nonproprietary Names (INN) Quality Assurance and Safety: Medicines Medicines Policy and Standards The use of stems in the selection of International Nonproprietary Names (INN) for pharmaceutical substances FORMER DOCUMENT NUMBER: WHO/PHARM S/NOM 15 © World Health Organization 2006 All rights reserved. Publications of the World Health Organization can be obtained from WHO Press, World Health Organization, 20 Avenue Appia, 1211 Geneva 27, Switzerland (tel.: +41 22 791 3264; fax: +41 22 791 4857; e-mail: [email protected]). Requests for permission to reproduce or translate WHO publications – whether for sale or for noncommercial distribution – should be addressed to WHO Press, at the above address (fax: +41 22 791 4806; e-mail: [email protected]). The designations employed and the presentation of the material in this publication do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. The mention of specific companies or of certain manufacturers’ products does not imply that they are endorsed or recommended by the World Health Organization in preference to others of a similar nature that are not mentioned. Errors and omissions excepted, the names of proprietary products are distinguished by initial capital letters.
    [Show full text]
  • Taenia Infections Iowa State University Center for Food Security and Public Health
    Center for Food Security and Public Health Center for Food Security and Public Health Technical Factsheets 5-1-2005 Taenia Infections Iowa State University Center for Food Security and Public Health Follow this and additional works at: http://lib.dr.iastate.edu/cfsph_factsheets Part of the Animal Diseases Commons, and the Veterinary Infectious Diseases Commons Recommended Citation Iowa State University Center for Food Security and Public Health, "Taenia Infections" (2005). Center for Food Security and Public Health Technical Factsheets. 131. http://lib.dr.iastate.edu/cfsph_factsheets/131 This Report is brought to you for free and open access by the Center for Food Security and Public Health at Iowa State University Digital Repository. It has been accepted for inclusion in Center for Food Security and Public Health Technical Factsheets by an authorized administrator of Iowa State University Digital Repository. For more information, please contact [email protected]. Taenia Etiology Taenia spp. are long, segmented, parasitic tapeworms (family Taeniidae, subclass Infections Cestoda). These parasites have an indirect life cycle, cycling between a definitive and an intermediate host. The following Taenia species are zoonotic, with humans serving Taeniasis, as the definitive host, the intermediate host, or both. Non-zoonotic species of Taenia also exist. Cysticercosis, Neurocysticercosis, Taeniasis Coenurosis, The adult tapeworms live in the intestines of the definitive hosts. This infection is Neurocoenurosis called taeniasis. Humans are the definitive hosts for Taenia solium (the pork tapeworm) and T. saginata (the beef tapeworm). Humans are also the definitive hosts for T. asiatica, a newly recognized tapeworm found in Asia. It is currently uncertain Last Updated: May 2005 whether T.
    [Show full text]
  • Etude Rétrospective Des Déclarations D'effets Indésirables Graves Lors D
    Etude rétrospective des déclarations d’effets indésirables graves lors d’utilisation d’antiparasitaires externes chez le chat et le chien Kim Schumacher To cite this version: Kim Schumacher. Etude rétrospective des déclarations d’effets indésirables graves lors d’utilisation d’antiparasitaires externes chez le chat et le chien. Médecine vétérinaire et santé animale. Université Paris-Est Créteil Val de Marne (UPEC); École nationale vétérinaire d’Alfort, 2016. Français. tel- 01874183 HAL Id: tel-01874183 https://tel.archives-ouvertes.fr/tel-01874183 Submitted on 14 Sep 2018 HAL is a multi-disciplinary open access L’archive ouverte pluridisciplinaire HAL, est archive for the deposit and dissemination of sci- destinée au dépôt et à la diffusion de documents entific research documents, whether they are pub- scientifiques de niveau recherche, publiés ou non, lished or not. The documents may come from émanant des établissements d’enseignement et de teaching and research institutions in France or recherche français ou étrangers, des laboratoires abroad, or from public or private research centers. publics ou privés. ÉCOLE NATIONALE VÉTÉRINAIRE D’ALFORT Année 2016 ÉTUDE RÉTROSPECTIVE DES DÉCLARATIONS D’EFFETS INDÉSIRABLES GRAVES LORS D’UTILISATION D’ANTIPARASITAIRES EXTERNES CHEZ LE CHAT ET LE CHIEN THÈSE Pour le DOCTORAT VÉTÉRINAIRE Présentée et soutenue publiquement devant LA FACULTÉ DE MÉDECINE DE CRÉTEIL le…………… par Kim Charlotte Amédée SCHUHMACHER Née le 4 décembre 1991 à Vélizy-Villacoublay (Yvelines) JURY Président : Pr. Professeur à la Faculté de Médecine de CRÉTEIL Membres Directeur : M. PERROT Sébastien Maître de conférences en Pharmacologie à l’ENVA Assesseur : Mme DARMON Céline Maître de conférences en Parasitologie à l’ENVA REMERCIEMENTS Au Professeur de la Faculté de médecine de Créteil, Qui nous a fait l’honneur d’accepter la présidence de notre jury de thèse, Hommage respectueux.
    [Show full text]
  • Sheet1 Page 1 a Abamectin Acetazolamide Sodium Adenosine-5-Monophosphate Aklomide Albendazole Alfaxalone Aloe Vera Alphadolone A
    Sheet1 A Abamectin Acetazolamide sodium Adenosine-5-monophosphate Aklomide Albendazole Alfaxalone Aloe vera Alphadolone Acetate Alpha-galactosidase Altrenogest Amikacin and its salts Aminopentamide Aminopyridine Amitraz Amoxicillin Amphomycin Amphotericin B Ampicillin Amprolium Anethole Apramycin Asiaticoside Atipamezole Avoparcin Azaperone B Bambermycin Bemegride Benazepril Benzathine cloxacillin Benzoyl Peroxide Benzydamine Bephenium Bephenium Hydroxynaphthoate Betamethasone Boldenone undecylenate Boswellin Bromelain Bromhexine 2-Bromo-2-nitropan-1, 3 diol Bunamidine Buquinolate Butamisole Butonate Butorphanol Page 1 Sheet1 C Calcium glucoheptonate (calcium glucoheptogluconate) Calcium levulinate Cambendazole Caprylic/Capric Acid Monoesters Carbadox Carbomycin Carfentanil Carnidazole Carnitine Carprofen Cefadroxil Ceftiofur sodium Centella asiatica Cephaloridine Cephapirin Chlorine dioxide Chlormadinone acetate Chlorophene Chlorothiazide Chlorpromazine HCl Choline Salicylate Chondroitin sulfate Clazuril Clenbuterol Clindamycin Clomipramine Clopidol Cloprostenol Clotrimazole Cloxacillin Colistin sulfate Copper calcium edetate Copper glycinate Coumaphos Cromolyn sodium Crystalline Hydroxycobalamin Cyclizine Cyclosporin A Cyprenorphine HCl Cythioate D Decoquinate Demeclocycline (Demethylchlortetracycline) Page 2 Sheet1 Deslorelin Desoxycorticosterone Pivalate Detomidine Diaveridine Dichlorvos Diclazuril Dicloxacillin Didecyl dimethyl ammonium chloride Diethanolamine Diethylcarbamazine Dihydrochlorothiazide Diidohydroxyquin Dimethylglycine
    [Show full text]
  • Simparica Trio
    Simparica Trio and Simparica Satisfaction Guarantee If you or your clients feel that Simparica TrioTM (sarolaner, moxidectin, and pyrantel chewable tablets) or Simparica® (sarolaner) Chewables aren’t providing sufficient protection, please call our medical support team to discuss our Satisfaction Guarantee. We will work with you to ensure that you and your clients are satisfied with the performance of Simparica Trio or Simparica or we will refund the cost of your purchase.* The Simparica Trio and Simparica Satisfaction Guarantee is available to any individual who has purchased Simparica Trio or Simparica from a veterinarian or via a veterinarian’s prescription from a Zoetis approved online distributor.** HEARTWORM DISEASE GUIDELINES (SIMPARICA TRIO ONLY): If any dog determined by a licensed veterinarian to be free of heartworm infection at the onset of treatment with Simparica Trio develops heartworm disease, we will provide reimbursement (up to $1,000 and provide Diroban® (melarsomine dihydrochloride) or provide reasonable acquisition costs of melarsomine dihydrochloride) associated with the diagnosis and treatment of heartworm disease and provide a year’s supply of Simparica Trio or ProHeart® 6 (moxidectin) or ProHeart® 12 (moxidectin). Canine Heartworm Reimbursement Requirements: • Simparica Trio was used, at all times, according to its label directions. • Confirmation of heartworm-positive status by two separate blood samples using at least two different brands of antigen tests are required to document heartworm positive status. – The use of an antigen test will be the standard for determining heartworm status. – Knott’s or any filter test for the detection of microfilariae is nots ufficient evidence for pretreatment heartworm negative status.
    [Show full text]
  • NADA FOI Summary
    I. GENERAL INFORMATION A. File Number NADA 140-915 B. Sponsor Ciba-Geigy Animal Health Ciba-Geigy Corporation P.O. Box 18300 Greensboro, NC 27419 C. Proprietary Name INTERCEPTOR® D. Established Name milbemycin oxime tablets E. Dosage Form, Route of Administration and Recommended Dosage The ingredients of INTERCEPTOR are formulated into various sized tablets to be administered orally (swallow) as appropriate for the weight of the dog (see below) at monthly dosing intervals. The tablets supply the recommended minimum dose level of 0.5 mg milbemycin oxime per kilogram (0.23 mg/lb.) of body weight. Dog Weight Tablets per Milbemycin Tablet Color Month Oxime per Tablet Up to 10 lbs. 1 2.30 mg Brown 11-25 lbs. 1 5.75 mg Green 26-50 lbs. 1 11.50 mg Yellow 51-100 lbs. 1 23.0 mg White Dogs over 100 lbs. are provided the appropriate combination of these tablets. F. Indication INTERCEPTOR tablets are indicated for use in the prevention of heartworm disease caused by Dirofilaria immitis and control of adult hookworm infections caused by Ancylostoma caninum in dogs. II. EFFECTIVENESS The New Animal Drug Application for milbemycin oxime tablets contains adequate and well-controlled studies which demonstrate efficacy in preventing heartworm disease and controlling hookworm infections in dogs. A. Dose Establishment Thirteen controlled studies were undertaken to establish and confirm the optimal effective dose of milbemycin oxime against the tissue migratory phases of Freedom of Information Summary NADA 140-915 Page 2 of 36 Dirofilaria immitis (canine heartworm) and adult intestinal phases of Ancylostoma sp., principally A.
    [Show full text]
  • EUROPEAN PHARMACOPOEIA 10.0 Index 1. General Notices
    EUROPEAN PHARMACOPOEIA 10.0 Index 1. General notices......................................................................... 3 2.2.66. Detection and measurement of radioactivity........... 119 2.1. Apparatus ............................................................................. 15 2.2.7. Optical rotation................................................................ 26 2.1.1. Droppers ........................................................................... 15 2.2.8. Viscosity ............................................................................ 27 2.1.2. Comparative table of porosity of sintered-glass filters.. 15 2.2.9. Capillary viscometer method ......................................... 27 2.1.3. Ultraviolet ray lamps for analytical purposes............... 15 2.3. Identification...................................................................... 129 2.1.4. Sieves ................................................................................. 16 2.3.1. Identification reactions of ions and functional 2.1.5. Tubes for comparative tests ............................................ 17 groups ...................................................................................... 129 2.1.6. Gas detector tubes............................................................ 17 2.3.2. Identification of fatty oils by thin-layer 2.2. Physical and physico-chemical methods.......................... 21 chromatography...................................................................... 132 2.2.1. Clarity and degree of opalescence of
    [Show full text]
  • Addendum A: Antiparasitic Drugs Used for Animals
    Addendum A: Antiparasitic Drugs Used for Animals Each product can only be used according to dosages and descriptions given on the leaflet within each package. Table A.1 Selection of drugs against protozoan diseases of dogs and cats (these compounds are not approved in all countries but are often available by import) Dosage (mg/kg Parasites Active compound body weight) Application Isospora species Toltrazuril D: 10.00 1Â per day for 4–5 d; p.o. Toxoplasma gondii Clindamycin D: 12.5 Every 12 h for 2–4 (acute infection) C: 12.5–25 weeks; o. Every 12 h for 2–4 weeks; o. Neospora Clindamycin D: 12.5 2Â per d for 4–8 sp. (systemic + Sulfadiazine/ weeks; o. infection) Trimethoprim Giardia species Fenbendazol D/C: 50.0 1Â per day for 3–5 days; o. Babesia species Imidocarb D: 3–6 Possibly repeat after 12–24 h; s.c. Leishmania species Allopurinol D: 20.0 1Â per day for months up to years; o. Hepatozoon species Imidocarb (I) D: 5.0 (I) + 5.0 (I) 2Â in intervals of + Doxycycline (D) (D) 2 weeks; s.c. plus (D) 2Â per day on 7 days; o. C cat, D dog, d day, kg kilogram, mg milligram, o. orally, s.c. subcutaneously Table A.2 Selection of drugs against nematodes of dogs and cats (unfortunately not effective against a broad spectrum of parasites) Active compounds Trade names Dosage (mg/kg body weight) Application ® Fenbendazole Panacur D: 50.0 for 3 d o. C: 50.0 for 3 d Flubendazole Flubenol® D: 22.0 for 3 d o.
    [Show full text]
  • Selection of New Chemicals to Be Used in Conditioned Aversion for Non-Lethal Predation Control 2
    1 Selection of new chemicals to be used in conditioned aversion for non-lethal predation control 2 3 Jorge Tobajasa,*, Pilar Gómez-Ramíreza,b,c, Pedro María-Mojicab, Isabel Navasb,c, 4 Antonio Juan García-Fernándezb,c, Pablo Ferrerasa, Rafael Mateoa 5 6 aInstituto de Investigación en Recursos Cinegéticos (IREC), CSIC-UCLM-JCCM, Ronda de 7 Toledo No. 12, 13071, Ciudad Real, Spain. 8 bToxicology Area, Department of Health Sciences, Faculty of Veterinary, University of 9 Murcia, Campus de Espinardo, 30100 Murcia, Spain. 10 cToxicology and Risk Assessment Group, Biomedical Research Institute of Murcia (IMIB- 11 Arrixaca), University of Murcia, Campus de Espinardo, 30100 Murcia, Spain. 12 13 *Corresponding author 14 E-mail address: [email protected] (J. Tobajas) 15 1 16 Abstract 17 The use of conditioned food aversion (CFA) can reduce the predation conflict and 18 therefore the incidence of illegal poisoning, which is one of the most important 19 conservation threats for predators and scavengers around the world. CFA is a robust 20 learning paradigm that occurs when animals associate a food with a discomfort 21 induced by a chemical, thereby avoiding that food in subsequent encounters. We 22 reviewed the potential of 167 chemical compounds to be used in CFA, considering 23 effects, margin of safety, accessibility, and detectability. After the review, 15 24 compounds fulfilled the required characteristics, but only five were finally selected to 25 be tested in CFA assays with dogs. Of the tested compounds, thiabendazole, thiram 26 and levamisole caused target food rejection by dogs and reduced the time spent eating 27 during post-conditioning.
    [Show full text]